PREVENTION OF ANTRACYCLIN ANTIBIOTIC DOXORUBICIN СARDIOTOXICITY: A ROLE OF ACE-INHIBITOR PERINDOPRIL

PREVENTION OF ANTRACYCLIN ANTIBIOTIC DOXORUBICIN СARDIOTOXICITY: A ROLE OF ACE-INHIBITOR PERINDOPRIL

Show other versions (1)

<p><strong>Aim</strong> – to study how anthracyclines influence on cardiovascular system in patients with lymphomas and whether angiotensin-converting enzyme inhibitor Perindopril is cardioprotective in these patients.</p><p><br /><strong>Subjects and method...

Full description

Bibliographic Details
Main Authors:	E. V. Pravdivtseva, N. G. Poteshkina, A. M. Svanadze, D. S. Rilskiy
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	angiotensin-converting enzyme inhibitor antracyclin cardiotoxicity diastolic disfunction chemotherapy
Online Access:	http://klinitsist.abvpress.ru/index.php/Klin/article/view/102

Similar Items

PREVENTION OF ANTRACYCLIN ANTIBIOTIC DOXORUBICIN СARDIOTOXICITY: A ROLE OF ACE-INHIBITOR PERINDOPRIL
by: E. V. Pravdivtseva, et al.
Published: (2014-07-01)

Management of Refractory/Relapsed Acute Leukemia with Heart Limitation by Anthracycline-free Chemotherapy Regimens in Pediatric Patients: New Hypothesis and New Approach
by: Babak Abdolkarimi, et al.
Published: (2018-04-01)

Editorial: Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-Oncology: From Bench to Bedside
by: Canan G. Nebigil, et al.
Published: (2020-08-01)

Efficacy of a fixed-dose combination of perindopril and amlodipine in the treatment of hypertensive patients. A clinical case
by: N G Poteshkina, et al.
Published: (2014-12-01)

Diastolic disorder inherent to doxorubicin cardiotoxicity
by: Lilia Tacu, et al.
Published: (2021-10-01)

Long-term QT prolongation in monkeys after doxorubicin administration at doses similar to breast cancer therapy
by: George M. Bodziock, et al.
Published: (2023-12-01)

Echocardiographic evaluation of diastolic dysfunction in young and healthy patients with psoriasis: A case-control study
by: Elio Gorga, et al.
Published: (2018-09-01)

New Possibilities in Heart Failure: The Effects of Tadalafil on Diastolic Function in Patients Undergoing Robot-Assisted Radical Prostatectomy
by: Felice Crocetto, et al.
Published: (2022-06-01)

Cardiotoxicity of doxorubicin – causes, prevention, prospects
by: Paweł Wesołowski, et al.
Published: (2022-11-01)

Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model
by: Marah Freiwan, et al.
Published: (2022-02-01)

Cross-Sectional Associations between Homoarginine, Intermediate Phenotypes, and Atrial Fibrillation in the Community—The Gutenberg Health Study
by: Christoph Niekamp, et al.
Published: (2018-08-01)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Irwin K. Cheah, et al.
Published: (2023-01-01)

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
by: Himani Kumari, et al.
Published: (2020-05-01)

The Role of ACE, ACE2, and AGTR2 Polymorphisms in COVID-19 Severity and the Presence of COVID-19-Related Retinopathy
by: Kristina Jevnikar, et al.
Published: (2022-06-01)

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
by: Urszula Tyrankiewicz, et al.
Published: (2021-06-01)

Divergent Cardiac Effects of Angiotensin II and Isoproterenol Following Juvenile Exposure to Doxorubicin
by: Kevin Agostinucci, et al.
Published: (2022-03-01)

Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study
by: Melissa Y. Y. Moey, et al.
Published: (2019-07-01)

From gene to protein - experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
by: Sheila K Patel, et al.
Published: (2014-06-01)

Comparing Flaxseed and Perindopril in the Prevention of Doxorubicin and Trastuzumab-Induced Cardiotoxicity in C57Bl/6 Mice
by: Cameron R. Eekhoudt, et al.
Published: (2022-04-01)

CHANGE OF THE LEFT VENTRICLE FUNCTIONING IN LYMPHOMA TREATED WITH ANTHRACYCLINE ANTIBIOTICS
by: K. V. Shuykova, et al.
Published: (2016-01-01)

Tissue Doppler Imaging and Focal, Late-Onset Anthracycline-Induced Cardiovascular Disease in Long Term Survivors of Childhood Cancer: A Research Article
by: Prakadeshwari Rajapreyar, et al.
Published: (2016-08-01)

Thymosin-α1 binds with ACE and downregulates the expression of ACE2 in human respiratory epithelia
by: Yu-Hang Zhang, et al.
Published: (2022-02-01)

Influence of trimetazidine on myocardium energy balance during chemotherapy with doxorubicin and cyclophosphamide
by: A. A. Avagimyan
Published: (2022-06-01)

Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model
by: Rohit M. Oemrawsingh, et al.
Published: (2016-03-01)

FUNCTIONAL CONDITION OF THE MYOCARDIUM IN ACUTE CORONARY SYNDROME
by: A. N. Zakirova, et al.
Published: (2001-02-01)

NEUROGENIC DISFUNCTIONS OF LOWER URINARY TRACT (NDLUT)
by: Y. G. Alyaev, et al.
Published: (2022-12-01)

Evaluation of the Association between Multilobar Involvement and ACE Inhibitor Use in SARS-CoV-2 Patients
by: Dilay Satilmis, et al.
Published: (2023-01-01)

Perindopril-induced angioedema of the lips and tongue: a case report
by: Fawaz Abdullah Alharbi, et al.
Published: (2018-12-01)

ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients
by: David S. Weisman, et al.
Published: (2020-01-01)

Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy
by: Yu. A. Vasyuk, et al.
Published: (2021-10-01)

Protection against Doxorubicin-Induced Cardiac Dysfunction Is Not Maintained Following Prolonged Autophagy Inhibition
by: Ryan N. Montalvo, et al.
Published: (2020-10-01)

ACE2 Attenuates Epithelial-Mesenchymal Transition in MLE-12 Cells Induced by Silica
by: Li S, et al.
Published: (2020-04-01)

Left ventricular diastolic function and cardiotoxic chemotherapy
by: Haider Rashid, et al.
Published: (2024-04-01)

Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?
by: Jasmine A. Luzum, et al.
Published: (2016-03-01)

Leucine and perindopril to improve physical performance in people over 70 years with sarcopenia: the LACE factorial RCT
by: Miles D Witham, et al.
Published: (2022-08-01)

Neopetroside-B alleviates doxorubicin-induced cardiotoxicity via mitochondrial protection
by: Chang Shin Yoon, et al.
Published: (2023-09-01)

ACE- inhibitor induced angioedema requiring an emergency surgical airway
by: Bhargav Patel, et al.
Published: (2014-12-01)

Allogeneic mitochondrial transplantation ameliorates cardiac dysfunction due to doxorubicin: An in vivo study
by: Farshid Maleki, et al.
Published: (2023-12-01)

Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
by: Naci Şenkal, et al.
Published: (2020-07-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)